sulfadiazine has been researched along with Fuchs' Endothelial Dystrophy in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Fuchs' Endothelial Dystrophy: Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jad, A | 1 |
| Céline, T | 1 |
| Bahram, B | 1 |
| Phuc, L | 1 |
| Nathalie, C | 1 |
1 other study available for sulfadiazine and Fuchs' Endothelial Dystrophy
| Article | Year |
|---|---|
Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?
Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Female; Fuchs' Endothelial Dystrophy; Fundus | 2013 |